Opportunity
Federal Register #2026-20749
DEA revokes Vladimir Romaniv, P.A.’s controlled-substance registrations
Posted
October 09, 2026
Identifier
2026-20749
This is a DEA regulatory enforcement decision involving a medical practitioner, not a procurement opportunity. - Government agency: U.S. Department of Justice, Drug Enforcement Administration (DEA). - Subject: Vladimir Romaniv, P.A., of Yonkers, New York. - Action: The DEA revoked Romaniv’s controlled-substance registrations and barred renewal or modification of the affected registration, as well as other pending applications for DEA registrations in New York, Massachusetts, and New Jersey. - Basis: The decision concerned overlapping opioid prescriptions allegedly issued without examinations or a legitimate doctor-patient relationship and without required supervising-physician information. - Procurement: No products, services, quantities, part numbers, OEMs, or vendors are requested or identified.
Description
The Drug Enforcement Administration issued a decision and order concerning Vladimir Romaniv, P.A. The agency grants the Government’s request for final agency action and revokes Romaniv’s DEA registration. The notice describes allegations involving controlled-substance prescriptions, including prescriptions issued without an examination or a legitimate doctor-patient relationship. The order also addresses Romaniv’s other DEA registrations and pending registration applications.